Oesophageal Cancer Trial, Recruiting (NCT02972372)

Oesophageal Cancer Trial, Recruiting NCT02972372 Sponsor: The First Affiliated Hospital of Henan University of Science and Technology Condition: Oesophageal Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT02972372 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Oesophageal Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are of Chinese ethnicity.
You have been diagnosed with a specific type of esophageal cancer called squamous cell cancer.
Your cancer is located in the middle or lower part of the food pipe (esophagus).
Your cancer can be removed with surgery (it is considered "resectable").
Your cancer is at a specific stage as determined by your doctor — roughly meaning it has not spread to distant parts of the body but may or may not have spread to nearby lymph nodes (confirm with trial site).

Who may not be able to join:

Your cancer has spread to distant organs (such as the liver or lungs) or has grown into nearby structures like the windpipe, the main artery near the heart (descending aorta), or certain nearby nerves.
You have a serious existing health condition or are in poor overall physical health that would make chest surgery too risky for you.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Shegan Gao, MD, PhD, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology

Phone: +86 18638859977

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT02972372

Sponsor: The First Affiliated Hospital of Henan University of Science and Technology

Phase: Not Applicable

Status: Recruiting

Condition: Oesophageal Cancer

Trial contact: +86 18638859977

More information: https://clinicaltrials.gov/study/NCT02972372

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are of Chinese ethnicity.
You have been diagnosed with a specific type of esophageal cancer called squamous cell cancer.
Your cancer is located in the middle or lower part of the food pipe (esophagus).
Your cancer can be removed with surgery (it is considered "resectable").
Your cancer is at a specific stage as determined by your doctor — roughly meaning it has not spread to distant parts of the body but may or may not have spread to nearby lymph nodes (confirm with trial site).

Who may not be able to join:

Your cancer has spread to distant organs (such as the liver or lungs) or has grown into nearby structures like the windpipe, the main artery near the heart (descending aorta), or certain nearby nerves.
You have a serious existing health condition or are in poor overall physical health that would make chest surgery too risky for you.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The First Affiliated Hospital of Henan University of Science and Technology

Registry

ClinicalTrials.gov

Start date

1 November 2016

Est. completion

1 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

2-year disease-free survival rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov